IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing. This applies to all persons who view this site.

THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED (THE “SEBI ICDR REGULATIONS”).

The following disclaimer applies to the Draft Abridged Prospectus dated August 26, 2026 (the “Draft Abridged Prospectus”) to the draft red herring prospectus dated August 26, 2026 (“DRHP”) of Aragen Life Sciences Limited (the “Company”) filed with the Securities and Exchange Board of India (the “SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”), and hosted on this website in relation to the initial public offering of the equity shares of face value of ₹10 each (“Equity Shares”) of the Company (the “Offer”). 

The Draft Abridged Prospectus has been made available on this website in electronic form solely to comply with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”). You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Draft Abridged Prospectus. By accessing the Draft Abridged Prospectus, you agree to follow the following terms and conditions, including any modifications to them from time to time. You should read the Draft Abridged Prospectus and seek professional advice before taking any action. 

The contents of the Draft Abridged Prospectus are for your information only and is intended solely to provide background information on the Company and you acknowledge that access to the Draft Abridged Prospectus is intended for use by you only and you agree not to forward the Draft Abridged Prospectus on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. The Draft Abridged Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. You may not distribute a copy of the Draft Abridged Prospectus to any person outside India. The information in this portion of our website, including the Draft Abridged Prospectus, is not intended for, and may not be accessed in or by, or distributed or transmitted in, into or to, directly or indirectly, the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”) or any other jurisdiction where it is unlawful to do so. All persons residing outside of the United States who wish to access the Draft Abridged Prospectus contained on the following page of this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website or require registration or approval for any acquisition of securities by them. No part of the contents of the Draft Abridged Prospectus shall be copied or duplicated in any form by any means or redistributed. The Draft Abridged Prospectus does not amount to, or is intended to be, a prospectus or an offer document, in terms of the Companies Act, 2013, and the SEBI ICDR Regulations, and nothing in the Draft Abridged Prospectus constitutes an offer or an invitation by or on behalf of either the Company or any of the members of the syndicate to subscribe for or purchase any of the securities described therein. Neither the Company, the BRLMs nor their respective affiliates represent that the contents of the Draft Abridged Prospectus herein are accurate or complete. The information contained in the Draft Abridged Prospectus may not be updated since its original publication date and may not reflect the latest updates, if any.

The Draft Abridged Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The Equity Shares in the Offer have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold (a) within the U.S. only to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act and referred to in the Draft Red Herring Prospectus as “U.S. QIBs”; for the avoidance of doubt, the term U.S. QIBs does not refer to a category of institutional investor defined under applicable Indian regulations and referred to in the Draft Red Herring Prospectus as “QIBs”) in transactions exempt from or not subject to the registration requirements of the U.S. Securities Act; and (b) outside of the U.S. in offshore transactions as defined in and in compliance with Regulation S and the applicable laws of the jurisdiction where those offers and sales are made. No public offering of the Equity Shares or other securities is being made in the United States.

Any person into whose possession the Draft Abridged Prospectus comes is required to inform himself or herself about and to observe any such restrictions. The Company, and Axis Capital Limited, Citigroup Global Markets India Private Limited, Goldman Sachs (India) Securities Private Limited and JM Financial Limited (collectively, the “Book Running Lead Managers”) and their respective affiliates, directors, officers, agents, representatives, advisers and employees do not accept any liability whatsoever, direct or indirect, that may arise from the use of the information contained on this website. The information in the Draft Abridged Prospectus is as of the date thereof and neither the Company, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees are under any obligation to update or revise the Draft Abridged Prospectus to reflect circumstances arising after the date thereof. The Company has taken all necessary steps to ensure that the contents of the Draft Abridged Prospectus as appearing on this website are identical to the Draft Abridged Prospectus filed with SEBI and the Stock Exchanges. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company, the Book Running Lead Managers nor any of their respective affiliates, directors, officers, agents, representatives, advisers or employees accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of the Draft Abridged Prospectus in electronic format.  

Any potential investor should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the red herring prospectus, which may be filed by the Company with the Registrar of Companies, Telangana at Hyderabad (the “RoC”) and SEBI in the future, including the section titled “Risk Factors”. Potential investors should not rely on the Draft Abridged Prospectus filed with SEBI. Any decision on whether to invest in the equity shares described in the Draft Abridged Prospectus must be made solely on the basis of the red herring prospectus. 

You are accessing this website at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses. Neither the Company, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website, or by use of this website or the Draft Abridged Prospectus. Neither the Company nor any of its affiliates or their respective directors, officers and employees will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. 

Failure to comply with this disclaimer may result in a violation of the applicable laws of India and other jurisdictions. Any other information contained in, or that can be accessed via our website does not constitute a part of the Draft Abridged Prospectus.

IF YOU ARE NOT PERMITTED TO VIEW THE MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.

The information is current only as of its date and shall not, under any circumstances, create any implication that the information contained therein is correct as of any time subsequent to the date thereof or that there has been no change in the financial condition or affairs of the Company since such date. This document may be updated from time to time and there is no undertaking the Company to post any such amendments or supplements on this website.

The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.

To access this information, you must confirm, by pressing on the button marked “I Confirm”, that at the time of access, you are located in India and have read the disclaimer set out above and you agree to be bound by its terms. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.

I CONFIRM I DO NOT CONFIRM